These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 1980731)

  • 41. [Neuroleptic-like activity of the tripeptide neurotensin analog GZR-123].
    Guzevatykh LS; Ostrovskaia RU; Gudasheva TA; Zaĭtseva NI; Voronina TA
    Eksp Klin Farmakol; 2002; 65(1):3-6. PubMed ID: 12025780
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Simultaneous catalepsy and apomorphine-induced stereotypic behavior in mice.
    Yurek DM; Randall PK
    Life Sci; 1985 Nov; 37(18):1665-73. PubMed ID: 4058245
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Enhanced effect of haloperidol and apomorphine after hypophysectomy: pharmacokinetic considerations.
    Lloyd KG; Bianchetti G; Worms P; Morselli PL
    J Pharm Pharmacol; 1983 Mar; 35(3):166-9. PubMed ID: 6132974
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Catalepsy after microinjection of haloperidol into the rat medial prefrontal cortex.
    Klockgether T; Schwarz M; Turski L; Sontag KH
    Exp Brain Res; 1988; 70(2):445-7. PubMed ID: 3384045
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Effects of dextromethorphan on dopamine dependent behaviours in rats.
    Gaikwad RV; Gaonkar RK; Jadhav SA; Thorat VM; Jadhav JH; Balsara JJ
    Indian J Exp Biol; 2007 Aug; 45(8):712-9. PubMed ID: 17877148
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Behavioural effects after cholinergic stimulation of the reticular thalamic nucleus in rats.
    Kolasiewicz W; Sauss C; Block F; Sontag KH
    J Neural Transm Gen Sect; 1992; 87(3):163-73. PubMed ID: 1581016
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Studies on the participation of the dopaminergic system in the central effects of chelidonine.
    Kleinrok Z; Szponar J; Matuszek B; Jagiełło-Wójtowicz E
    Pol J Pharmacol Pharm; 1990; 42(5):417-24. PubMed ID: 2098751
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Is morphine-induced catalepsy related to activation of dopaminergic neurones?
    Moleman P; Versluis DJ; Bruinvels J
    Psychopharmacology (Berl); 1978 Dec; 60(1):35-9. PubMed ID: 104343
    [No Abstract]   [Full Text] [Related]  

  • 49. Relative importance of the dopaminergic system in haloperidol-catalepsy and the anticataleptic effect of antidepressants and methamphetamine in rats.
    Al-Khatib IM; Fujiwara M; Ueki S
    Pharmacol Biochem Behav; 1989 May; 33(1):93-7. PubMed ID: 2528750
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Study of the participation of the dopaminergic transmission system in the effects of two newly synthesized barbiturates.
    Getova D; Markovska V
    Acta Physiol Pharmacol Bulg; 1988; 14(2):56-62. PubMed ID: 2851915
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Effects of buspirone on dopamine dependent behaviours in rats.
    Dhavalshankh AG; Jadhav SA; Gaikwad RV; Gaonkar RK; Thorat VM; Balsara JJ
    Indian J Physiol Pharmacol; 2007; 51(4):375-86. PubMed ID: 18476392
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Significance of the cerebral dopaminergic neurotransmission for the individual differences in learning and memory (experiments on rats).
    Kehayov R; Markovska V; Kamburova T
    Acta Physiol Pharmacol Bulg; 1989; 15(1):76-82. PubMed ID: 2549763
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Effects of a novel neurotensin peptide analog given extracranially on CNS behaviors mediated by apomorphine and haloperidol.
    Cusack B; Boules M; Tyler BM; Fauq A; McCormick DJ; Richelson E
    Brain Res; 2000 Feb; 856(1-2):48-54. PubMed ID: 10677610
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Evidence for increased apomorphine-sensitive dopaminergic effects after acute treatment with morphine.
    Scheel-Krüger J; Golembiowska K; Mogilnicka E
    Psychopharmacology (Berl); 1977 Jun; 53(1):55-63. PubMed ID: 407614
    [No Abstract]   [Full Text] [Related]  

  • 55. Ketotifen can antagonise changes in sensitivity of cerebral dopamine receptors: behavioural correlates in rodent and primate.
    Barnes JC; Barnes NJ; Barnes NM; Costall B; Domeney AM; Naylor RJ
    Neuropharmacology; 1987 Jul; 26(7A):693-700. PubMed ID: 3114665
    [TBL] [Abstract][Full Text] [Related]  

  • 56. The behavioural effects of pramipexole, a novel dopamine receptor agonist.
    Maj J; Rogóz Z; Skuza G; Kołodziejczyk K
    Eur J Pharmacol; 1997 Apr; 324(1):31-7. PubMed ID: 9137910
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [Influence of the intracaudate administration of kainic acid on the effects of the prolonged use of haloperidol and apomorphine on rats].
    Zharkovskiĭ AM; Allikmets LKh; Nurk AM
    Farmakol Toksikol; 1982; 45(1):10-2. PubMed ID: 7198997
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Neuroleptic-induced catalepsy as a model of Parkinson's disease. I. Effect of dopaminergic agents.
    Elliott PJ; Close SP; Walsh DM; Hayes AG; Marriott AS
    J Neural Transm Park Dis Dement Sect; 1990; 2(2):79-89. PubMed ID: 1977409
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Differential changes in dopaminergic receptor sensitivity induced by agonist drugs.
    Aizenstein ML; Scavone C; Steinschreiber S; de-Lucia R
    Braz J Med Biol Res; 1985; 18(4):541-8. PubMed ID: 3836709
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Synthesis and preliminary pharmacological assessment of novel 9-substituted pyrimidino-[2,1-f]-purines.
    Pawłowski M; Drabczyńska A; Gorczyca M; Malec D; Modzelewski J
    Pol J Pharmacol Pharm; 1991; 43(1):61-70. PubMed ID: 1771164
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.